Barclays analyst Luke Sergott raised the firm’s price target on Labcorp (LH) to $271 from $249 and keeps an Equal Weight rating on the shares.

Labcorp Holdings Inc. LH, or Labcorp, is slated to report its fourth-quarter 2024 results on Feb. 6 before the opening bell.

Labcorp Holdings Inc. (NYSE:LH), a prominent $20.8 billion healthcare diagnostics company, announced today an expansion of its credit facilities, underscoring the company's ongoing financial strategy.

Labcorp (LH) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations. We recently compiled a list of th ...

Labcorp (NYSE: LH), a global leader of innovative and comprehensive laboratory services, has once again been named to ...

Labcorp Holdings Inc. closed 1.61% short of its 52-week high of $247.99, which the company reached on November 11th.